The physiological rationale for the sleep finding is that GH is secreted preferentially during slow-wave sleep, and the ghrelin system has independent links to sleep architecture, so a ghrelin-receptor agonist plausibly modifies both
There were nine unique authors, of which two were male, one female, and seven were of unknown gender
In our analysis, participants with any GLP-1RA exposure had 75% lower odds of any SUD compared with non-exposed participants (OR = 0.25, 95% CI 0.220.30)
Nothing about the dose size changes across phases in the documented protocol only the frequency changes
As Wegovy is a prescription medication, always consult a licensed healthcare provider before starting, stopping, or changing your dose
High-purity research peptide